Criticism Mounts
House Judiciary Committee Chairman Jim Jordan (R-OH) recently faced controversy for spreading COVID-19 conspiracy theories during a hearing, defending Robert F. Kennedy Jr.'s claim linking baseball legend Hank Aaron's death to the C...
Moderna vaccine for Australia
The Australian government has reached an agreement with US pharmaceutical company Moderna allowing local facilities to produce up to 100 million doses of coronavirus vaccine each year over the next 10 years. Australian ...
This week
The S&P 500, Nasdaq Composite and Dow Jones indices finished trading on Friday with declines of -0.72%, -1.23% and -0.68%, having lost -1.58%, -1.76% and -1.9% last week respectively. Shares in sectors such as energy, telecom services ...
Omicron vaccine
U.S. company Pfizer said that a vaccine that is adapted to the omicron strain of coronavirus will be ready in March 2022. Pfizer CEO Albert Bourla announced this on Monday.
"This vaccine ...
New strain and the economy
US stock indices fell before the opening of trading on Tuesday after Fed Chairman Jerome Powell said risks to the economy, the labour market and inflation could become more difficult with...
Fighting a new strain
The stock market recovered slightly at the premarket on Monday after a sharp fall on Friday when the World Health Organisation (WHO) said that the new COVID-19 strain first identified in South Africa was a "strain of concern".
...
Booster vaccines
The FDA and CDC in the US on Friday approved Pfizer (PFE)/BioNTech (BNTX) and Moderna (MRNA) booster vaccines against COVID-19 for all adults in the US. Revaccination with J&...
Government contract for Pfizer
Shares in Pfizer (PFE) have risen amid reports that the US government has ordered 10 million courses of treatment with its Pfizer Paxlovid tablets for COVID-19.
President Joe Biden said o...
Shares have fallen
Moderna (MRNA) shares have lost most of their growth since the start of 2021, last week's financial report was significantly worse than market analysts' forecasts and confirmed the fears of many investors.
Moderna (MRNA)'s share ...
2021 outlook
Pfizer (PFE) shares rose sharply by 4% on Tuesday after the company beat analysts' Q3 revenue and earnings estimates and raised its sales forecast for 2021. Pfizer investors are encouraged by expected sales of booster doses of COVID-19 ...
The American vaccine
The United States sent Taiwan 1.5 million doses of the COVID-19 vaccine produced by Moderna. This was announced on Sunday by Ned Price, head of the State Department's press office, on Twitter.
...
Vaccine sales
J&J Company (JNJ) reported its financial results for the third quarter of 2021 earnings per share exceeded market analysts' forecasts, but revenues fell short of estimates. Sales of COVID-19 vaccines t...
Friday trading
US stock indices rallied on Friday as investors absorbed Goldman Sachs' sharp gain and an unexpected rise in retail sales. The Dow Jones Industrial Average jumped 207 points, or 0.59%, while the S&P 500 and Nasdaq Composite indice...
2-in-1 vaccine
Moderna's shares have increased dramatically after the announcement of the development of a comprehensive booster vaccine that simultaneously protects against new strains of the COVID-19 virus and seasona...
New York Stock Exchange premarket on Tuesday
Shares in Boeing (NYSE:BA) fell 1% after European budget airline Ryanair, one of the US plane maker's biggest customers, broke off talks over a deal to buy the 737 MAX 10 jets over a disagreement over pri...
Best time to buy Uber shares
Uber shares are trading at a lower price today than on the first day of trading. However, investors have four strong arguments for buying Uber stock right now to take advantage of the lower price.
Uber (UBER) shares are...
Friday trading
US stock indices ended Friday's trading lower on inflation concerns. The second quarter reporting season also remains in the spotlight. This week, major US banks and a number of other companies ...
Vaccine approval application
Novavax will be another major international supplier of vaccines against COVID-19, as trials of its NVX-CoV2373 vaccine have shown an overall effectiveness of 90.4% with good tolerability. Novavax expects coronaviru...
Shares plummet
Moderna (NASDAQ:MRNA) shares tumbled more than 10% at the opening of trading in New York on Thursday on the back of the Biden administration's decision to support a COVID-19 vaccine intellectual...
Vaccination made more accessible to New Yorkers
New York City authorities have expanded access to vaccination against the new coronavirus for the city's entire population, regardless of neighborhood. This was announced on Fr...
- 1
- 2
NEW YORK NEWS
News from GlobalNY.biz is the freshest and most relevant information about high-profile events in the region. The task of the resource's news feed is to convey to readers with maximum accuracy and objectivity information about important events in business, politics, economy, healthcare, culture and other spheres of life in New York.
GlobalNY.biz news is a coverage of economic processes taking place in New York, the latest news of public life, incidents and an overview of political events. New York news is information about the activities of small and medium-sized businesses, the work of housing and communal services and utilities, the implementation of significant projects.
The site's journalists describe not only the life of the region, but also talk about the current state of the US economy. Everything you need to know about innovations in the field of industry and agriculture, economy and power is collected in the "News" section at GlobalNY.biz.
New York news quickly informs the reader, shows the real picture and opens up hot topics. Communication with government structures and business enables us to provide our readers with reliable, information-rich material. The main page of the portal contains the key news of New York!
Alena Potapova
Development Director
